• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒感染在HIV感染者与非HIV感染者之间的差异及影响因素

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection.

作者信息

Yang Jianhui, Strodl Esben, Zhang Dandan, Jiang Haibo, Chu Kun, Tan Shiwen, Ye Zehao, Shi Hongbo, Tong Feng, Chen Weiqing

机构信息

Ningbo Municipal Centre for Disease Control and Prevention, 1166 Fanjiang'an Road, Haishu District, Ningbo City, 315016, Zhejiang Province, PRC, China.

School of Psychology and Counselling, Queensland University of Technology, Brisbane, Australia.

出版信息

BMC Public Health. 2025 Jan 30;25(1):386. doi: 10.1186/s12889-025-21400-8.

DOI:10.1186/s12889-025-21400-8
PMID:39885441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11783751/
Abstract

BACKGROUND

There are mixed findings in the literature regarding the association between HIV status and the risk of COVID-19 infection. Thus, we aimed to estimate the association between characteristics of HIV infection and the risk of COVID-19 Infection in a Chinese sample.

METHODS

We conducted a cross-sectional survey of 1995 people living with HIV (PLWH) and 3503 HIV-negative adults in Ningbo, China. We compared the prevalence rates of the SARS-CoV-2 infection and the long nucleic acid conversion time (more than 2 weeks) among PLWH and HIV-negative participants, respectively. In addition, we explored the risk factors associated with SARS-CoV-2 infection and the long nucleic acid conversion time among the two groups.

RESULTS

Overall, 1485/1995 (74.4%) PLWH and 2864/3503 (81.8%) HIV-negative people were infected with SARS-CoV-2. Among the SARS-CoV-2-infected participants, 437/1485 (29.4%) PLWH and 649/2864 (22.7%) HIV-negative people had the long nucleic acid conversion time. After controlling for the potential confounders, the rate of the SARS-CoV-2 infection was lower among the PLWH than the HIV-negative group (adjusted OR = 0.836, 95% CI = 0.706-0.990). However, PLWH had a significantly higher risk of the long nucleic acid conversion time after the SARS-CoV-2 infection (adjusted OR = 1.417, 95% CI = 1.176-1.707) than the HIV negative participants. Compared with those who did not receive ART, PLWH adults who received ART significantly had the increased risk of SARS-CoV-2 infection. Furthermore, HIV-negative participants receiving COVID-19 vaccines significantly displayed the decreased likelihood of the long nucleic acid conversion time after the SARS-CoV-2 infection.

CONCLUSIONS

Our study indicates that different HIV Infection status was significantly and differently associated with the SARS-CoV-2 infection and the long nucleic acid conversion time. However, the further studies are needed to confirm the effect of ART and COVID-19 vaccines on SARS-CoV-2 infection in PLWH.

摘要

背景

关于艾滋病毒感染状况与新型冠状病毒肺炎(COVID-19)感染风险之间的关联,文献中的研究结果不一。因此,我们旨在评估中国样本中艾滋病毒感染特征与COVID-19感染风险之间的关联。

方法

我们对中国宁波的1995名艾滋病毒感染者(PLWH)和3503名艾滋病毒阴性成年人进行了横断面调查。我们分别比较了PLWH和艾滋病毒阴性参与者中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的患病率以及长核酸转换时间(超过2周)。此外,我们探讨了两组中与SARS-CoV-2感染和长核酸转换时间相关的危险因素。

结果

总体而言,1485/1995(74.4%)的PLWH和2864/3503(81.8%)的艾滋病毒阴性者感染了SARS-CoV-2。在感染SARS-CoV-2的参与者中,437/1485(29.4%)的PLWH和649/2864(22.7%)的艾滋病毒阴性者有长核酸转换时间。在控制潜在混杂因素后,PLWH中SARS-CoV-2感染率低于艾滋病毒阴性组(调整后的比值比[OR]=0.836,95%置信区间[CI]=0.706-0.990)。然而,与艾滋病毒阴性参与者相比,PLWH在感染SARS-CoV-2后出现长核酸转换时间的风险显著更高(调整后的OR=1.417,95%CI=1.176-1.707)。与未接受抗逆转录病毒治疗(ART)的人相比,接受ART的PLWH成年人感染SARS-CoV-2的风险显著增加。此外,接种COVID-19疫苗的艾滋病毒阴性参与者在感染SARS-CoV-2后出现长核酸转换时间的可能性显著降低。

结论

我们的研究表明,不同的艾滋病毒感染状况与SARS-CoV-2感染和长核酸转换时间存在显著且不同的关联。然而,需要进一步研究来证实ART和COVID-19疫苗对PLWH中SARS-CoV-2感染的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/79ea94535985/12889_2025_21400_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/8f813fd6e60c/12889_2025_21400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/4d281c799f84/12889_2025_21400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/92b340e52455/12889_2025_21400_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/b3eb35555b72/12889_2025_21400_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/b67a19aff710/12889_2025_21400_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/79ea94535985/12889_2025_21400_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/8f813fd6e60c/12889_2025_21400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/4d281c799f84/12889_2025_21400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/92b340e52455/12889_2025_21400_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/b3eb35555b72/12889_2025_21400_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/b67a19aff710/12889_2025_21400_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20d0/11783751/79ea94535985/12889_2025_21400_Fig6_HTML.jpg

相似文献

1
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection.新型冠状病毒感染在HIV感染者与非HIV感染者之间的差异及影响因素
BMC Public Health. 2025 Jan 30;25(1):386. doi: 10.1186/s12889-025-21400-8.
2
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China.HIV 感染者对奥密克戎变异株感染的脆弱性较低:来自中国的横断面研究结果。
BMC Infect Dis. 2023 Nov 14;23(1):795. doi: 10.1186/s12879-023-08768-x.
3
Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.中国武汉 HIV 感染者感染 SARS-CoV-2 的风险。
Front Public Health. 2022 Apr 29;10:833783. doi: 10.3389/fpubh.2022.833783. eCollection 2022.
4
Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China.比较中国 HIV 感染者和 HIV 阴性个体对 SARS-CoV-2 灭活疫苗的免疫反应:一项横断面研究。
Viruses. 2022 Jan 28;14(2):277. doi: 10.3390/v14020277.
5
People living with HIV with the Omicron variant infection have milder COVID-19 symptoms: results from a cross-sectional study.奥密克戎变异株感染的 HIV 感染者的 COVID-19 症状较轻:一项横断面研究的结果。
AIDS Res Ther. 2024 Aug 10;21(1):53. doi: 10.1186/s12981-024-00633-4.
6
SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.与未感染 HIV 的人群相比,HIV 感染者感染 SARS-CoV-2 的情况:来自 MACS-WIHS 联合队列研究的调查结果。
J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):1-8. doi: 10.1097/QAI.0000000000002822.
7
SARS-CoV-2 seroprevalence and associated factors among people living with HIV in Sierra Leone.塞拉利昂 HIV 感染者中 SARS-CoV-2 血清流行率及相关因素。
Immun Inflamm Dis. 2024 Jul;12(7):e1338. doi: 10.1002/iid3.1338.
8
The vast majority of SARS-CoV-2 infections were asymptomatic in a clinic-based cohort of people with and without HIV in four African countries.在四个非洲国家针对有和没有感染艾滋病毒的人群开展的一项基于诊所的队列研究中,绝大多数感染新冠病毒的人没有症状。
BMC Infect Dis. 2025 Mar 12;25(1):345. doi: 10.1186/s12879-025-10692-1.
9
SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.2022 年 12 月至 2023 年 2 月中国东南部 HIV 感染者中 SARS-CoV-2 感染、住院和相关因素的横断面调查。
JMIR Public Health Surveill. 2024 Apr 17;10:e51449. doi: 10.2196/51449.
10
Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey.中国广西地区 HIV 感染者对 COVID-19 疫苗的接种意愿及影响因素:一项横断面调查。
BMC Infect Dis. 2022 May 16;22(1):471. doi: 10.1186/s12879-022-07452-w.

本文引用的文献

1
COVID-19 Testing Among People with HIV: A Population Level Analysis Based on Statewide Data in South Carolina.艾滋病毒感染者中的 COVID-19 检测:基于南卡罗来纳州全州数据的人群水平分析。
AIDS Behav. 2024 Oct;28(Suppl 1):22-32. doi: 10.1007/s10461-023-04244-4. Epub 2023 Dec 18.
2
SARSCoV-2 antibody prevalence and titers in persons living with HIV cared for at a large tertiary reference center in Mexico City.墨西哥城一家大型三级参考中心接受治疗的 HIV 感染者中 SARS-CoV-2 抗体的流行率和滴度。
Virol J. 2023 Dec 15;20(1):300. doi: 10.1186/s12985-023-02261-2.
3
Epidemiological features of SARS-CoV-2 Omicron infection under new control strategy: a cross-sectional study of the outbreak since December 2022 in Sichuan, China.
奥密克戎变异株感染实施“乙类乙管”后疫情防控特征的横断面研究:中国四川 2022 年 12 月以来的暴发调查。
BMC Public Health. 2023 Dec 8;23(1):2463. doi: 10.1186/s12889-023-17361-5.
4
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China.HIV 感染者对奥密克戎变异株感染的脆弱性较低:来自中国的横断面研究结果。
BMC Infect Dis. 2023 Nov 14;23(1):795. doi: 10.1186/s12879-023-08768-x.
5
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis.HIV感染者中新冠病毒加强针疫苗接种的免疫原性和有效性:一项系统评价与荟萃分析
Front Med (Lausanne). 2023 Oct 9;10:1275843. doi: 10.3389/fmed.2023.1275843. eCollection 2023.
6
Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19.灭活 COVID-19 疫苗对 COVID-19 无症状或轻症患者核酸转阴的影响。
BMC Infect Dis. 2023 Jun 30;23(1):443. doi: 10.1186/s12879-023-08315-8.
7
COVID-19 infection in people living with HIV.COVID-19 感染在 HIV 感染者中。
Br Med Bull. 2023 Sep 12;147(1):20-30. doi: 10.1093/bmb/ldac031.
8
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.真实世界中灭活 SARS-CoV-2 疫苗的有效性及其影响因素:系统评价和荟萃回归分析。
BMC Med. 2023 Apr 27;21(1):160. doi: 10.1186/s12916-023-02861-3.
9
Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China.2022年末全国奥密克戎疫情对中国新冠疫情未来展望的影响
Emerg Microbes Infect. 2023 Dec;12(1):2191738. doi: 10.1080/22221751.2023.2191738.
10
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.先前感染 SARS-CoV-2 和混合免疫对奥密克戎变异株和重症疾病的保护效力:系统评价和荟萃回归分析。
Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18.